Application no. and date | 20734283.3 (espacenet) (Federated) (European Patent Register), 20200615 | Patent/reg. no. and date | DK/EP 3982960, 20230628 | Publication date | 20220420 | Priority no. and date | US 201962861725 P, 20190614, GB 201910116, 20190715 | EP pub. no. and date |
EP 3982960 20220420 | Effective date | | Applicant/owner | Kalvista Pharmaceuticals Limited, Porton Science Park Bybrook Road Porton Down, Salisbury SP4 0BF Wiltshire, GB | Applicant ref. no. | P82662DK01 | Inventor | FEENER, Edward Paul, 24 Peter Road
North Reading, Massachusetts 01864, US, MARSH, Sally Louise, c/o Kalvista Pharmaceuticals Limited Porton Science Park Bybrook Road, Porton Down
Salisbury, Wiltshire SP4 0BF, GB, MAETZEL, Andreas, 102 Glen Haven Drive
Chapel Hill, North Carolina 27516, US, SMITH, Michael David, 2377 E Stringham Avenue
Salt Lake City, Utah 84109, US, YEA, Christopher Martyn, c/o Kalvista Pharmaceuticals Limited Porton Science Park Bybrook Road, Porton Down
Salisbury, Wiltshire SP4 0BF, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/444 (2006.01) , A61P 7/00 (2006.01) | Title | BEHANDLINGER AF HEREDITÆRT ANGIOØDEM | Int. application no. | GB2020051439 | Int. publication no. | WO2020249977 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|